Paratek Pharmaceuticals, Inc.
USD2.23
+0.04 (+1.83%)
CEO
Evan Loh FACC, FAHA,
IPO Date
2009-02-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.19
Prev. Close
$2.19
Day Low
$2.19
Day High
$2.24
52W Low
$1.29
52W High
$3.65
Market Cap
$0.13B
Volume
4.48M
| -3.7 |
| 31 Dec 2020 | FY | 80.1% | -267.2% | 113.7% | -65.7% | -2.46 | 6.85 | -2.4 |
| 31 Dec 2019 | FY | 78.9% | -778.5% | 324.2% | -51.3% | -6.62 | 10.06 | -1.0 |
| 31 Dec 2018 | FY | 100.0% | -656.4% | -235.5% | -37.4% | 4.80 | 14.41 | -1.4 |
| 31 Dec 2017 | FY | 100.0% | -706.0% | -107.8% | -54.4% | 0.72 | 9.56 | -5.4 |
| 31 Dec 2016 | FY | 100.0% | -384951.7% | -155.9% | -82.2% | 0.54 | 6.47 | -2.8 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -70.0% | -48.6% | 0.19 | 6.95 | -4.4 |
| 31 Dec 2014 | FY | 100.0% | -410.8% | -18.7% | -16.2% | 0.00 | 27.09 | -5.5 |
| 31 Dec 2013 | FY | 100.0% | -1571.0% | -38.3% | -37.3% | 0.00 | 38.19 | -1.3 |
| -1.8 |
| 31 Dec 2022 | Q4 | 85.8% | -9.9% | 4.2% | -4.1% | -1.51 | 3.66 | -3.6 |
| 30 Sept 2022 | Q3 | 84.3% | -90.7% | 15.2% | -16.1% | -1.56 | 3.11 | -1.4 |
| 30 Jun 2022 | Q2 | 82.3% | -80.1% | 14.8% | -13.5% | -1.73 | 4.24 | -1.2 |
| 31 Mar 2022 | Q1 | 84.6% | -78.7% | 12.8% | -10.5% | -1.83 | 4.62 | -2.2 |
| 31 Dec 2021 | Q4 | 83.9% | -110.1% | 25.2% | -17.5% | -2.00 | 4.86 | -1.8 |
| 30 Sept 2021 | Q3 | 80.0% | -84.9% | 17.3% | -10.0% | -2.43 | 5.25 | -3.3 |
| 30 Jun 2021 | Q2 | 82.4% | 17.5% | -9.8% | 5.4% | -2.56 | 7.32 | 8.3 |
| 31 Mar 2021 | Q1 | 81.4% | -123.8% | 15.4% | -11.5% | -2.12 | 6.18 | -4.5 |